A detailed history of Pictet Asset Management Sa transactions in Ardelyx, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 29,376 shares of ARDX stock, worth $151,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,376
Previous 38,246 23.19%
Holding current value
$151,873
Previous $183,000 45.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$3.23 - $4.95 $28,650 - $43,906
-8,870 Reduced 23.19%
29,376 $99,000
Q1 2023

May 10, 2023

BUY
$2.68 - $4.79 $102,499 - $183,198
38,246 New
38,246 $183,000
Q4 2021

Feb 10, 2022

SELL
$0.86 - $1.7 $346,210 - $684,369
-402,570 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$1.27 - $8.17 $511,263 - $3.29 Million
402,570 New
402,570 $531,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $799M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.